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Abstract 
This study investigated the effect of protein supplementation on recovery following muscle-damaging 
exercise, which was induced with a concurrent exercise design. Twenty-four well-trained male cyclists 
were randomised to three independent groups receiving 20 g protein hydrolysate, iso-caloric 
carbohydrate or low-calorific placebo supplementation, per serve. Supplement serves were provided 
twice daily, from the onset of the muscle-damaging exercise, for a total of four days and in addition 
to a controlled diet (6 g·kg-1·d-1 carbohydrate, 1.2 g·kg-1·d-1 protein, remainder from fat). Following the 
concurrent exercise session at time-point 0 h; a simulated high-intensity road cycling trial and 100 
drop-jumps, recovery of outcome measures was assessed at 24, 48 and 72 h. The concurrent exercise 
protocol was deemed to have caused exercise-induced muscle damage (EIMD), owing to time effects 
(p<0.001), confirming decrements in maximal voluntary contraction (peaking at 15 ± 10%) and 
countermovement jump performance (peaking at 8 ± 7%), along with increased muscle soreness, 
creatine kinase and C-reactive protein concentrations. No group or interaction effects (p>0.05) were 
observed for any of the outcome measures. The present results indicate that protein supplementation 
does not attenuate any of the indirect indices of EIMD imposed by concurrent exercise, when 
employing great rigour around the provision of a quality habitual diet and the provision of appropriate 
supplemental controls.  
 
Keywords: Concurrent training, exercise recovery, protein supplementation, EIMD, muscle soreness  
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Introduction 
Performing a novel or unaccustomed bout of exercise can result in exercise-induced muscle damage 
(EIMD) that can negatively affect the ability to meet a high intensity demand during subsequent 
exercise. Specifically, a temporary reduction in maximal force production, increased muscle soreness, 
muscle swelling, passive tension, and the appearance of intramuscular proteins in the blood 
(Howatson and van Someren, 2008) are observed following the exercise. Of the indirect indices utilised 
in research, those that measure the functional capacity of the muscle, such as force production, 
appear to be the most meaningful index of EIMD (Warren et al., 1999). The presence of EIMD and 
hence, a decline in the force generating capacity of the muscle, poses obvious implications for athletic 
populations. 
 
Performing strenuous exercise bouts that precipitate EIMD is associated with an increase in both 
muscle protein degradation and synthesis (Phillips et al., 1997). The provision of adequate nutrition is 
required to confer a positive protein balance following the exercise stimulus to increase myfobrillar 
protein synthesis rates (Moore et al., 2009, Tipton et al., 2003). Therefore, the consumption of 
sufficient protein following the exercise stimulus is a pre-requisite for muscle anabolism and hence, 
muscle remodelling following mechanical stress (Levenhagen et al., 2002). Further, this critical 
adaptive process of skeletal muscle might facilitate an attenuation in the indirect markers of EIMD 
following protein consumption (Saunders, 2007). Willoughby et al., (2003) reported an up-regulation 
of the ubiquitin-proteolytic pathway 48 h following an eccentric exercise bout; indicative of conditions 
that result in a reduced myofibrillar protein content (Hobler et al., 1998). Hence, efforts to alter 
protein metabolism and support myofibrillar protein synthesis as soon as possible following EIMD 
might facilitate recovery. 
 
Additional protein is frequently consumed by elite and recreational athletes (Petroczi and Naughton, 
2008, Tsitsimpikou et al., 2011) with the intention to improve exercise recovery (Erdman et al., 2007). 
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The evidence is equivocal, with research suggesting efficacy (Cockburn et al., 2008, Etheridge et al., 
2008, Hoffman et al., 2010) and a lack of benefits (Green et al., 2008, White et al., 2008, Wojcik et al., 
2001) for protein or coingested-protein supplementation to attenuate indices of EIMD. Fractional 
synthesis rates and fractional net balance are still elevated at 48 h following resistance exercise 
(Phillips et al., 1997). Hence, muscle remodelling can be stressed for at least 48 hours following a 
resistance exercise stimulus. Therefore, efforts to investigate the efficacy of a protein supplement 
following EIMD might benefit from providing additional protein across this timeframe of remodelling, 
increasing bioavailability compared to single bolus supplementation models. Further, it is suggested 
that study designs where participants are in negative nitrogen and/ or energy balance will present the 
greatest potential for ergogenic effects associated with protein supplementation (Pasiakos et al., 
2014). It is therefore critical that research in this field is conducted with rigorous dietary control, 
whereby an intervention is assessed against appropriate controls and in addition to a standardised 
habitual diet. 
 
Beyond the limitations of the literature, there is scant research concerning recovery from concurrent 
exercise. Concurrent exercise involves the simultaneous incorporation of both endurance and 
resistance exercise, (Fyfe et al., 2014) and is a prevalent training method for elite and recreational 
athletes that are aiming to elicit divergent physiological adaptations in parallel. Previous work 
examining recovery from EIMD has used resistance (Harrison and Gaffney, 2004, Miyama and Nosaka, 
2004) or endurance (Bell et al., 2014, Betts et al., 2009) stimuli in isolation. Hypotheses exist for both 
mechanical and metabolic processes to determine the initial event of muscle fibre injury (Armstrong 
et al., 1991). Eccentric muscle action protocols have historically proved an effective means to impose 
damage, with sarcomere length inhomogeneity leading to mechanical disruption of the cell membrane 
(Morgan, 1990, Proske and Morgan, 2001). Further, exercise of a prolonged nature can result in 
degenerative changes to the muscle fibre, which lead to fibre necrosis, evidenced by the accumulation 
of macrophages and phagocytes (Armstrong, 1986). Hence, a concurrent exercise stimulus, 
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incorporating both eccentric muscle actions through resistance exercise and prolonged endurance 
activity incorporating high-intensity efforts, could prove an effective method to elicit muscle damage. 
Beyond the rationale of investigating concurrent exercise in the context of the hypotheses of muscle 
fibre injury, it is of interest to observe the profile of recovery from the combination of demanding 
resistance and endurance stimuli.  
 
It is therefore of interest to observe whether indices of EIMD imposed by a concurrent exercise 
stimulus can be attenuated with protein supplementation. Beyond this, increasing our understanding 
of recovery from EIMD within such a pertinent training paradigm would be of importance, particularly 
so, given recent requests for greater specificity and context in post-exercise recovery 
recommendations (Minett and Costello, 2015). We hypothesised that the magnitude of EIMD would 
be reduced with protein supplementation compared to controls. Consequently, the aim of the study 
was to investigate the effect of protein supplementation on recovery following muscle-damaging 
exercise, induced with a concurrent exercise paradigm, in the context of a quality habitual diet which 
meets current guidelines (Thomas et al., 2016).  
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Materials and methods 
Participants 
Twenty-four male, well-trained endurance cyclists (age 27 ± 4 years; height 177.5 ± 7.9 cm; mass 73.7 
± 8.9 kg; V̇O2peak ϲϭ.Ϯ ± ϱ.ϴ ŵl∙kg-1∙ŵiŶ-1) who were regularly competing (at least a Category 3 British 
CǇĐliŶg liĐeŶĐe holdeƌ oƌ aŶ estiŵated ϭϲ.ϭ kŵ TT of чϮϯ ŵiŶ) ǀoluŶteeƌed to take paƌt iŶ the studǇ. 
Following completion of a questionnaire to assess for eligibility and contraindications to the study, all 
participants provided written, informed consent. Prior to data collection, all procedures were given 
institutional research ethics approval and subsequently registered as a clinical trial (ClinicalTrials.gov, 
www.clinicaltrials.gov, NCT02458599). All study procedures were conducted in a laboratory 
accredited by the British Association of Sport and Exercise Sciences.  
 
Experimental Design 
The study utilised an independent group design that was double-blind, randomised and placebo-
controlled (Figure 1). Following two preliminary trials for familiarisation to performance tests and 
collection of demographic characteristics, participants attended the laboratory on five consecutive 
days at the same time of day (± 1 h) to minimise the effects of diurnal variation. At each visit, 
participants were deemed fit for testing if they could confirm that they were free from concomitant 
medications/ vitamins and had refrained from external exercise, caffeine and alcohol since their last 
visit to the laboratory (24 h). Participants also refrained from consumption of nutritional supplements 
for the duration of the study period. In order, baseline data were collected for body mass (Seca 704 r, 
Seca, Hamburg, Germany), indices of muscle damage (creatine kinase)/ inflammation (C-reactive 
protein), perceived muscle soreness, isometric maximal voluntary contraction (MVC) of the dominant 
knee extensor, maximal countermovement jump (CMJ) height and cycling time trial (TT) performance.  
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Figure 1. Study schematic. MVC = maximal voluntary contraction; CMJ = countermovement jump; GXT = 
graded exercise test; PRO = protein; CHO = carbohydrate; PLA = placebo.  
 
Participants were then randomly assigned in a block fashion, using computer software, to one of three 
supplement groups; (1) whey protein hydrolysate, (2) iso-caloric carbohydrate, (3) low-calorific 
placebo. Supplements were consumed twice daily, for a period of four days, commencing at the end 
of the concurrent exercise visit, following the CMJ (Figure 1). Non-supplemental dietary intake was 
standardised (6 g·kg-1·d-1 carbohydrate, 1.2 g·kg-1∙d-1 protein, remainder from fat) and controlled 
during the trial (-48 to 72 h). Each group completed the concurrent exercise session at time-point 0 h; 
a simulated high-intensity road cycling trial and 100 drop-jumps. Recovery from the concurrent 
exercise bout was assessed by repeating baseline measures at 24, 48 and 72 h. Exceptions were TT 
performance (repeated at 72 h only) and MVC/ CMJ (also assessed at 0 h). TT performance has 
previously been reported to be impaired at 48 h following damaging exercise (Burt and Twist, 2011). 
However, TT performance was repeated only at 72 h, in a bid to improve ecological validity, by better 
mimicking the amount of time that would be allowed for recovery from a heavy training stimulus prior 
to a competitive effort. 
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Nutritional Supplement 
The nutritional content of the supplements are listed in Table 1. Participants ingested 500 ml of either 
HYDRO.365 Berry (Arla Foods Ingredients Group P/S, Viby, Denmark), Powerade ION4 Berry and 
Tropical (Coca-Cola Enterprises, Middlesex, UK) or Powerade Zero Berry and Tropical (Coca-Cola 
Enterprises, Middlesex, UK) on each supplement occasion. The supplement choice was such that the 
PRO condition provided 20 g of whey protein hydrolysate as an experimental intervention, with the 
CHO condition providing an iso-caloric control and the PLA condition a low-calorific placebo. This 
approach would help to establish whether potential ergogenic effects of protein supplementation 
were owing to protein or increased energy consumption. A total of eight supplemental beverages 
were consumed and these occurred at 3 h preceding, directly following, or 3 h following a laboratory 
visit during visits 4-7 (Figure 1). Each serving was in a ready-to-drink format, which was blinded to both 
participant and investigator, and dispensed by a scientist that was independent to the study. 
Beverages were dispensed on a daily basis, with one consumed immediately following the CMJ (visits 
4, 5 and 6) or 16.1 km TT protocols (visit 7) and the other(s) at a time detailed in the daily food plan. 
In order to test the blinding process at study completion, the dispensing scientist asked participants 
which supplemental condition they perceived to have been assigned to. The blind was not broken 
until all statistical analyses were complete. 
 
Table 1. Nutritional content of the supplements. 
 PRO CHO PLA 
Energy (kcal) 90 90 5 
Protein (g) 20 Nil Nil 
Carbohydrate (g) 1.85 20.5 Nil 
Fat (g) 0.05 Nil Nil 
Quantities are per 500 ml serve. PRO = protein; CHO = carbohydrate; PLA = placebo 
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Dietary Control 
Non-supplemental dietary intake was standardised (6 g·kg-1·d-1 carbohydrate, 1.2 g·kg-1·d-1 protein, 
remainder from fat) and controlled during the trial (-48 to 72 h). The diet was sourced from a tailored 
menu provider (Soulmatefood Ltd, Lancashire, UK) and designed in line with ACSM recommendations 
(Thomas et al., 2016). In detail, carbohydrate and protein were prescribed relative to body mass, 
before selecting a range (20 - 27%) for the contribution of energy from fat, which was within the range 
recommended by the ACSM guidelines; 20 - 35%. These criteria resulted in categories for daily total 
kcal, which were a result of body mass; 2,500 kcal = 63.0 - 69.4 kg/ 2,750 kcal = 69.5 - 76.4 kg/ 3,000 
kcal =76.5 - 83.3 kg/ 3,250 kcal = 83.4 - 90.3 kg/ 3,500 kcal = 90.4 - 97.2 kg. Food was delivered to 
paƌtiĐipaŶts͛ hoŵe addƌess oŶ tǁo oĐĐasioŶs aŶd laďelled suĐh that fouƌ ŵeals ǁeƌe pƌoǀided dailǇ, 
to be consumed at times specified in the participants͛ dailǇ food plaŶ. This plaŶ eŶsuƌed that food 
distribution throughout the day was standardised and that food was not consumed for at least 1 h 
following a supplement serving. Food content was analysed using dietary analysis software (Nutritics 
v4.108, Nutritics Ltd., Co. Dublin, Ireland), in order to confirm content against request. 
 
Assessment of Peak Oxygen Uptake (V̇O2peak) 
Following a graded 20 min warm-up (4 min incremental stages), participants cycled at a power output 
of 200 W using a magnetically braked cycle ergometer (Velotron, RacerMate Inc., Seattle, USA). Power 
output was subsequently increased by 4 W every 10 s (24 W·min-1) until volitional exhaustion. Expired 
gas and heart rate were collected throughout the test, with the test being terminated when the 
participant was unable to maintain the workload. Expired gas data were averaged across 30 s intervals 
using online gas analysis software (MetaSoft_Studio, Cortex., Leipzig, Germany), before downloading 
for subsequent assessment. V̇O2peak was calculated as the highest 30 s average collected during the 
maximal test. An online gas analyzer (Metalyzer 3B, Cortex., Leipzig, Germany) was used throughout 
the protocol to measure oxygen and carbon dioxide fractions and volume of gas in inspired and 
expired air. The analyzer was calibrated for oxygen and carbon dioxide fractions and gas volume (3 L 
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syringe), as per manufacturer͛s instructions. During the test, participants breathed through a low dead 
space (70 mL) mouth piece, low resistance turbine, while inspired and expired gas was sampled 
continuously at 50 Hz. Routine QA records demonstrated a laboratory coefficient of variation for V̇O2 
data of 1.8% in the range of 2.05–3.94 L·min-1. 
 
Muscle Damaging Concurrent Exercise 
The concurrent exercise session was performed in the fed state, with meal timing standardised at 2 h 
prior to exercise, and consisted of a high-intensity simulated cycling road race and a drop-jump 
protocol, separated by a 15 min rest period. The cycling protocol (Table 2) was performed using a 
magnetically braked cycle ergometer (Velotron, RacerMate Inc., Seattle, USA) and has previously been 
used to simulate the demands of cycling road racing (Vaile et al., 2008). In brief, participants 
completed a 10 min self-selected warm-up including 3 × 3 s sprints at 7, 8 and 9 min, before completing 
a total of 66 sprints of a 5, 10 or 15 s duration, with a work (W) to rest ratio of 1:6, 1:3 or 1:1. Sprints 
were divided into 9 sets, with a period of active recovery completed between sprints and between 
sets. Intensity during active recovery was maintained at 40%–50% W achieved at V̇O2peak. Furthermore, 
9 min of sustained effort was incorporated into the trial through the performance of time trials of 2 
min (after sets 3 and 6) and 5 min (after set 9) duration. During all sprints and time trials, participants 
were encouraged to complete as much work as possible and the total duration of the trial was 109 
min. Heart rate was continually recorded throughout each trial using wireless telemetry (T31 
transmitter, Polar Electro Ltd., Kempele, Finland) and participants were cooled with an electric fan on 
a standardised setting. Strong standardised verbal encouragement was provided throughout and 
water was made available to participants ad libitum.  
 
 
Table 2. High-intensity simulated cycling road race; sprint frequency/ duration and work to rest ratio 
composition (Vaile et al., 2008). 
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10 min warm up (self-selected pace) 
Set Number Sprint Frequency x Duration Work : Rest Ratio 
1 12 x 5 s 1 : 6 
2 12 x 5 s 1 : 3 
3 12 x 5 s 1 : 1 
4 min Active Recovery - 2 min TT - 4 min Active Recovery 
4 6 x 10 s 1 : 6 
5 6 x 10 s 1 : 3 
6 6 x 10 s 1 : 1 
4 min Active Recovery - 2 min TT - 4 min Active Recovery 
7 4 x 15 s 1 : 6 
8 4 x 15 s 1 : 3 
9 4 x 15 s 1 : 1 
5 min Active Recovery - 5 min TT - 5 min Active Recovery 
 
 
The allotted rest period of 15 min comprised passive rest (5 min), standardised dynamic stretching (5 
min) and a drop-jump briefing (5 min). Participants then performed a total of 100 drop-jumps from a 
height of 0.63 m, whereby they were encouraged to jump vertically with maximal force immediately 
upon landing. The protocol was separated into five sets of 20 drop-jumps, with 10 s rest between each 
jump and 120 s between each set. Strong standardised verbal encouragement was provided 
throughout. This protocol has consistently demonstrated a muscle damage response (Goodall and 
Howatson, 2008, Miyama and Nosaka, 2004) and was selected for the endurance trained cohort, due 
to a lower skill/ technical demand compared to more applied resistance stimuli. 
 
 
Performance Tests  
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Isometric MVC was assessed following a standardised warm up of 5 min at 200 W on a cycle ergometer 
(Wattbike, Wattbike Ltd., Nottingham, UK). Participants completed three, 3 s MVCs of the knee 
extensors, separated by 60 s rest, using a Cybex isokinetic dynamometer (Cybex Humac Norm, 
Computer Sports Medicine Inc., CA, USA). In a seated position, participants initiated a leg extension 
action against a fixed arm, secured proximal to the ankle joint, immediately above the malleoli. Peak 
toƌƋue ǁas assessed foƌ the paƌtiĐipaŶts͛ doŵiŶaŶt leg, at a kŶee joiŶt aŶgle of ϳϬ from horizontal, 
assessed with a goniometer (Bodycare Products, Warwickshire, UK). A knee joint angle of 70 has 
previously been reported to be susceptible to significant loss of isometric strength following a single 
bout of eccentric exercise (McHugh and Tetro, 2003). CMJ performance was assessed using the 
OptoJump system (OptoJump, Microgate S.r.l., Bolzano, Italy), with three maximal jumps performed 
on each testing occasion, each separated by 60 s rest. Participants were instructed to place their hands 
on their hips, descend rapidly to ~90 knee joint angle, and then jump as high as possible. Standardised 
verbal encouragement for each effort and the peak value generated across the three repetitions was 
used for data analysis, in both assessments. The intra-individual reliability of these measures returned 
a coefficient of variation of 3.8% and 0.9% for the MVC and CMJ protocols, respectively.  
 
Following a standardised 5 min warm up at an intensity of 50% V̇O2peak, participants completed a 16.1 
km TT using a magnetically braked cycle ergometer (Velotron, RacerMate Inc., Seattle, USA). The 
assessment required participants to complete a distance of 16.1 km in as short a time as possible, 
while being blinded to time elapsed. The trial started with the ergometer set in the lowest possible 
gear ratio, whereby after a 3 s count-down, the participant was responsible for manipulating gearing 
to a desired level. Feedback of performance data was withheld, except distance elapsed, which was 
communicated every 1.6 km and participants were permitted to change gears as and when they felt 
necessary. Heart rate was continually recorded throughout each trial, using wireless telemetry (T31 
transmitter, Polar Electro Ltd., Kempele, Finland) and participants were cooled with an electric fan at 
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a standardised setting, with water available ad libitum. The intra-individual reliability of these 
measures returned a coefficient of variation 1.1% for this protocol. 
 
Muscle Soreness Assessment 
Participants were asked to hold a fixed squat position at an ~90 joint angle, while rating perceived 
muscle soreness on a 20 cm visual analogue scale, consisting of a line from 0 cm (no pain) to 20 cm 
(pain as bad as it could be). Using similar scales, previous research reports significantly increased 
soreness following EIMD protocols (Goodall and Howatson, 2008, Mohr et al., 2016).  
 
Blood Sampling and Analysis 
A venous blood sample was collected from a branch of the basilica vein in the anti-cubital fossa region 
using venepuncture method, for assessment of indices of muscle damage (creatine kinase) and 
inflammation (C-reactive protein). A total of ~10mL of blood was collected into a silica additive serum 
vacutainer (367896, BD Diagnostics, Dubai, UAE) and rested for 60 min to clot. The vacutainer was 
then centrifuged at 1300x g, 25C for 10 min (Heraeus Multifuge 3SR Plus, Thermo Fisher Scientific 
IŶĐ., MA, USA). The ƌesultaŶt supeƌŶataŶt ǁas pipetted iŶto aliƋuots aŶd iŵŵediatelǇ stoƌed at −ϴϬ 
°C, for later analysis.  
 
Serum CK was analysed using a CK NAC-activated ELISA kit (Randox Laboratories Ltd., County Antrim, 
UK). Hence, a 10 L serum sample was mixed with 500 L of reagent and measured at 37C at a 340 
nm wavelength, using an Rx Monza clinical chemistry analyser (Randox Laboratories Ltd., County 
Antrim, UK). The manufacturer reports intra-assay and inter-assay coefficients of variation for this 
protocol at 1.6-2.3% and 3.4-3.9%, respectively. Serum C-reactive protein was analysed in duplicate 
using a Human CRP ELISA kit (R&D Systems Europe Ltd., Abingdon, UK). Hence, a 10 L serum sample 
underwent a 100-fold dilution with calibrator diluent, before being processed in accordance with the 
manufactuƌeƌ͛s iŶstƌuĐtioŶs. OptiĐal deŶsities ǁeƌe deteƌŵiŶed at ϱϰϬ Ŷŵ aŶd ϰϱϬ Ŷŵ, usiŶg a Fisheƌ 
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Scientific Multiskan FC Microplate Reader (Thermo Fisher Scientific Inc., MA, USA).  Blank subtracted 
values were averaged and 450 nm readings were corrected with 540 nm values. Standard and controls 
were plotted as a standard curve with data linearised by producing log scales of both axes. The 
manufacturer reports intra-assay and inter-assay coefficients of variation for this protocol at 3.8-8.3% 
and 6.0-7.0%, respectively. 
 
Statistical Analysis 
Data are presented as mean ± standard deviation (SD), with statistical significance set at pчϬ.Ϭϱ a 
priori. SpheƌiĐitǇ ǁas assuŵed if MauĐhlǇ͛s test sĐoƌe ƌetuƌŶed pшϬ.Ϭϱ, ǁith GƌeeŶhouse-Geiser 
adjustments made where appropriate. All criterion measures were analysed using a group (PRO vs. 
CHO vs. PLA) by time-point (-24, 0, 24, 48, 72 h) repeated measures analysis of variance (ANOVA). 
MVC and CMJ analysis included five time-points (-24, 0, 24, 48, 72 h), while four time-points (-24, 24, 
48, 72 h) were assessed for muscle soreness and blood markers, with just two time-points (-24 and 72 
h) used for analysis of TT performance. Significant main effects were further investigated using LSD 
post-hoc, pair-wise comparisons. All data analysis was performed using statistical software (IBM SPSS 
22 for Windows, New York, USA). Where appropriate, data were normalised using percentage change 
from baseline, to account for differences in baseline measures. Statistical power of the study was 
calculated using G*Power statistical software (v3.1.9, Düsseldorf, Germany) on the basis of research 
investigating the effect of protein-based supplementation vs. carbohydrate control on maximal 
muscle function (lower-body 1 repetition maximum or peak torque during extension/flexion) at 48 h 
post-damage (Cockburn et al., 2008, Hoffman et al., 2010, Rankin et al., 2015), returning a 
hypothesised effect size of 0.3 and a subsequent sample size of 21 subjects i.e. 7 subjects per group, 
ǁith α set at Ϭ.Ϭ5 and sufficient statistical power of 0.8 (Cohen, 1992).  
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Results 
No differences in demographic descriptive variables between groups were observed (p>0.05), upon 
initial presentation (Table 3). There were no significant differences in the prescribed energy intake, or 
contribution of macronutrients to daily energy intake between groups (p>0.05). Daily prescribed 
energy intake per group is listed in Table 4. The concurrent exercise protocol was deemed to have 
caused EIMD, owing to time effects (p<0.001), confirming decrements in MVC and CMJ performance, 
along with increased muscle soreness, CK and CRP. The only measure devoid of time effects was the 
16.1 km TT, which was assessed at baseline and 72 h only.  
 
Table 3. Baseline demographic descriptive data.  
Supp. Group Age (yr) Height (cm) Body Mass (kg) V̇O2peak (ŵl∙kg-1∙ŵiŶ-1) MVC (Nm) 
PRO 27 ± 3 178.8 ± 9.7 75.9 ± 8.9 62.3 ± 4.7 271.9 ± 55.9 
PLA 28 ± 5 174.9 ± 5.1 72.7 ± 8.4 60.0 ± 9.0 229.8 ± 32.2 
CHO 26 ± 5 178.9 ± 8.7 72.4 ± 10.0 61.2 ± 2.2 261.8 ± 50.1 
Values presented as mean ± SD. PRO = protein; CHO = carbohydrate; PLA = placebo 
 
Table 4.  Daily prescribed energy intake.  
Supp. Group Body Mass (kg) TOTAL (kcal) CHO (kcal) PRO (kcal) FAT (kcal) 
PRO 75.9 ± 8.9 2813 ± 320 1821 ± 213 364 ± 43 627 ± 88 
PLA 72.7 ± 8.4 2750 ± 327 1745 ± 201 349 ± 40 656 ± 111 
CHO 72.4 ± 10.0 2750 ± 327 1738 ± 241 348 ± 48 665 ± 73 
Values presented as mean ± SD. PRO = protein; CHO = carbohydrate; PLA = placebo 
 
Performance 
A time effect was observed for both MVC (F(2.7,57.6) = 30.305, p<0.001) and CMJ (F(2.8,57.7) = 7.342, 
p<0.001), with no group or interaction effects (p>0.05) (Figures 2 and 3). Peak detriment for MVC was 
at 0 h for all groups; 82.6 ± 7.9, 84.5 ± 11.1 and 88.9 ± 11.4 % of baseline for PRO, PLA and CHO, 
respectively, with significant decrements from baseline at 0 and 24 h (p<0.001). This was consistent 
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with CMJ performance, with all groups registering lowest values at 0 h; 93.4 ± 7.5, 91.3 ± 8.3 and 92.5 
± 5.6 % of baseline for PRO, PLA and CHO, respectively, with significant decrements from baseline at 
0 (p<0.001), 24 (p=0.032) and 48 h (p=0.036). No time effect was observed for TT time or average 
W∙kg-1 sustained during the TT (p>0.05) and neither of these measures displayed group or interaction 
effects (p>0.05).  
 
Figure 2. Isometric maximal voluntary contraction response (% change from baseline) to the concurrent 
exercise protocol in the PRO (n = 8), PLA (n = 8) and CHO (n = 8) groups. Absolute baseline values were 271.9 ± 
55.9, 229.8 ± 32.2 and 261.8 ± 50.1 Nm for PRO, PLA and CHO, respectively. *, significantly different from 
baseline (p<0.05). Values presented as mean ± SD. PRO = protein; CHO = carbohydrate; PLA = placebo. 
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Figure 3. Countermovement jump response (% change from baseline) to the concurrent exercise protocol in 
the PRO (n = 8), PLA (n = 8) and CHO (n = 8) groups. Absolute baseline values were 33.4 ± 4.3, 33.9 ± 2.8 and 
32.7 ± 3.5 cm for PRO, PLA and CHO, respectively. *, significantly different from baseline (p<0.05). Values 
presented as mean ± SD. PRO = protein; CHO = carbohydrate; PLA = placebo.  
 
Muscle Soreness 
A time effect, F(1.7,36.6) = 73.609, p<0.001 was observed (Figure 4), but similar to performance measures, 
there was no difference between groups (p>0.05), nor was there an interaction between group and 
time (p>0.05). Muscle soreness was significantly elevated from baseline at all time-points (p<0.001). 
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Figure 4. Muscle soreness response to the concurrent exercise protocol in the PRO (n = 8), PLA (n = 8) and CHO 
(n = 8) groups. *, significantly different from baseline (p<0.05). Values presented as mean ± SD. PRO = protein; 
CHO = carbohydrate; PLA = placebo.  
 
Serum Proteins 
Both CK and CRP displayed time effects, F(1.5,27.9) = 27.867, p<0.001 and F(1.1,20.4) = 19.765, p<0.001, 
respectively. However, there were no group or interaction effects (p>0.05) for either of these 
biomarkers of muscle damage and inflammation. Absolute baseline values for CK were 258.4 ± 103.1, 
185.3 ± 103.9 and 218.1 ± 56.7 IU∙L-1 for PRO, PLA and CHO, respectively. All groups displayed a similar 
CK profile, with peak values experienced at 24 h; 282.4 ± 166.2, 340.7 ± 167.2 and 291.1 ± 177.1 % of 
baseline for PRO, PLA and CHO, respectively. Both CK and CRP were significantly elevated from 
baseline at 24 and 48 h (p<0.05). Absolute baseline values for CRP were 1.13 ± 0.66, 2.04 ± 2.92 and 
0.66 ± 0.54 mg∙L-1 for PRO, PLA and CHO, respectively. The time course of CRP was similar to that of 
CK, with peak values experienced at 24 h; 205.6 ± 110.4, 260.4 ± 206.9 and 240.7 ± 177.9 % of baseline 
for PRO, PLA and CHO, respectively. 
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The body mass reduction experienced across the trial period for the pooled participants was 
significant F(3.8,79.2) = 9.399, p<0.001. However, there was no difference in the body mass reduction 
between groups (p>0.05); -0.75 ± 0.66, -1.08 ± 0.70 and -0.36 ± 0.47 kg for PRO, PLA and CHO, 
respectively. Upon exit questioning, none of the participants perceived to be receiving protein 
supplementation and only three participants noted to be unsure of which supplement condition they 
were receiving. Across all conditions, there was a group majority to select carbohydrate as the 
perceived treatment condition received (Table 5). 
 
Table 5. Participant selection of perceived treatment condition at the conclusion of study participation. 
Supplement Group PLA Count PRO Count CHO Count Unsure Count 
PRO 3 0 4 1 
PLA 0 0 7 1 
CHO 2 0 5 1 
PRO = protein; CHO = carbohydrate; PLA = placebo  
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Discussion 
The primary finding was that protein supplementation did not attenuate any of the indirect indices of 
EIMD. Beyond this, the research profiled the recovery from EIMD imposed within a concurrent training 
paradigm.  
 
In order to assess the efficacy of protein supplementation, it was of primary importance that the 
intense bout of concurrent exercise was of sufficient design to elicit a response in indirect indices of 
EIMD, which was suggestive of muscle damage. All five indices assessed in the 48 h following the 
concurrent exercise session displayed significant time effects, indicating that the concurrent exercise 
bout was effective in eliciting a muscle damage response. Isometric MVC performance was reduced 
by a peak magnitude of 15% from baseline across the three groups, with time effects at 0 and 24 h. A 
review by (Clarkson and Hubal, 2002) suggests that eccentric-biased exercise protocols result in force 
decrements of 10-65% for between 24 h to 2 wk, depending on whether a lower or higher-force 
eccentric exercise protocol has been utilised.  Hence, the decrement in magnitude of force and speed 
of return to baseline values observed in this study are at the lower end of the spectrum of reported 
values, compared to EIMD imposed exclusively through eccentric-biased muscle action protocols.  
 
The muted performance decrements observed in this study could have been influenced by the 
metabolic challenge of the cycling protocol, with high demand on the glycolytic pathway, performed 
prior to the drop-jump protocol. Endurance exercise is known to significantly deplete intra-muscular 
glycogen levels (Noakes et al., 1988), which is associated with a concomitant reduction in the capacity 
to produce optimal muscular strength (Jacobs et al., 1981). Similarly, 2 h of cycling at 65% maximal 
aerobic power reduced eccentric muscular peak torque by 14% in well-trained cyclists, with these 
outcomes ascribed to a decline in the neural input to the muscle and peripheral mechanisms (Lepers 
et al., 2000). If the maximal force output of the muscle was compromised due to the cycling protocol, 
it is feasible that this would compromise the subsequent drop-jump performance. Further, the lack of 
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time effect at 48 and 72 h for MVC performance might contribute to the lack of efficacy for protein 
supplementation. Previous research concerning eccentric muscle damage has reported the magnitude 
of EIMD to rise progressively from 0 to 48 h, with significance established at 48 h (Cockburn et al., 
2008). Authors postulate that thier observations may be related to protein metabolism research in 
animals; Lowe et al., (1995) displayed that the increase in protein degradation is not significant until 
48 h following eccentric contraction-induced injury, with protein balance declining from 24-336 h, 
resulting in a negative state from pre-damage values. If this were to hold true in human skeletal 
muscle, it is tenable to expect protein supplementation to display efficacy, if any, when protein 
metabolism is most stressed, possibly supporting recovery from 48 h onwards. As the deleterious 
effects in force output from our exercise stimulus were not significant and diminishing at 48 h post-
exercise, we may not have imposed damage of a sufficient length of time in order to investigate the 
benefit of protein in the recovery process of this outcome measure. 
 
CMJ performance declined by a peak magnitude of 8% from baseline across the three groups, with an 
effect for time at 0, 24 and 48 h. Using an identical drop-jump protocol, others have reported varying 
peak decrements in CMJ performance, lasting up to 96 h; ~8% (Howatson et al., 2012)  and ~25% 
(Miyama and Nosaka, 2004). It is feasible that the discrepancies in magnitude and resolution of CMJ 
performance might be explained in part by participant demographics, with Howatson et al., (2012) 
using a population regularly competing and Miyama and Nosaka, (2004) observing an un-trained 
population. The training history of the participants may represent a conditioning bout of exercise and 
lead to a reduction in the resolution and magnitude of EIMD indices in subsequent bouts, as has been 
discussed previously (McHugh, 2003). The repeated bout effect, facilitates a faster recovery of muscle 
function following a superseding bout of damaging exercise for up to 9 months (Nosaka et al., 2001), 
and may help to explain these findings.  This is especially true given that evidence suggests a 
prophylactic effect even when less-severe damaging exercise is performed prior to a more severe bout 
of damaging exercise (Clarkson and Tremblay, 1988). It should however be noted, that the participants 
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in our research were a well-trained cohort of endurance cyclists and as such, are unlikely to have 
benefited from the repeated bout effect. Exclusion criteria restricted individuals that had previously 
participated in a study involving activity to elicit EIMD, however participants were not excluded on the 
basis of strength training history. A more tenable explanation for the muted decrement in CMJ 
performance could be the preceding concentric work in the cycling trial. Nosaka and Clarkson, (1997) 
reported an attenuation of muscle damage from 12 maximal eccentric actions, when preceded by 100 
repetitions of concentric muscle actions. This attenuation was evident in several indices of muscle 
damage; including force output, muscle soreness, and CK activity.  
 
Perceived muscle soreness was significantly elevated from baseline at all time-points, with peak values 
expressed at 24 to 48 h. This response, with peak soreness of ~55% of maximum across all groups, is 
similar to that observed in the literature. Cockburn et al., (2008) reported a peak soreness of ~70% of 
maximum with time effects still apparent at the final time-point of 48 h, while others have reported 
peak values of ~60% of maximum soreness and time effects through to 72 h (Jackman et al., 2010, 
Rankin et al., 2015). An average peak CK value of 610 IU∙L-1 was observed at 24 h, across the three 
groups. This response in CK is consistent with other literature profiling recovery from EIMD with an 
eccentric muscle action bias; 539 IU∙L-1 (Cockburn et al., 2008), 757 IU∙L-1 (Green et al., 2008), 974 IU∙L-
1 (Miyama and Nosaka, 2004). The range in these reported values is likely explained by variation in the 
participant characteristics and protocol used to induce muscle damage, with the highest CK values 
observed in work by Miyama and Nosaka, (2004) which used a protocol of the highest volume, in a 
large muscle mass, in a student cohort with little or no training experience.  
 
The elevated levels of CK in blood is indicative of disruption to the muscle membrane, with peak values 
normally evident no earlier than 24 h post-exercise (Warren et al., 1999). This iŶĐƌease iŶ ͚leakage͛ of 
intramuscular proteins into the bloodstream is just one of the events that are observed following 
EIMD, which appear as part of the cascade of events following the disruption of the intracellular Ca2+ 
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homeostasis (Gissel and Clausen, 2001). The increased CRP values, which peaked at 24 h, suggest that 
the exercise stimulus was also sufficient to elicit an inflammatory response. Observations from 
biopsied muscle samples that have undergone eccentric muscle damage, suggest the addition of new 
sarcomeres and de novo synthesis in response to the stimulus (Yu et al., 2004, Yu et al., 2003). This 
remodelling of the muscle, with the associated reduction in contractile protein content (Warren et al., 
2002, Willoughby et al., 2003) is suggestive of an environment that would drive a requirement for 
protein uptake. Hence, the response in both CK and CRP subsequent to the concurrent exercise bout 
is suggestive of a stimulus that would place demands on protein availability, despite the lack of group 
effects reported in this study.  
 
It seems logical that the smaller responses in EIMD indices in this study, particularly MVC and CMJ 
performance, provide a smaller window for an intervention to display efficacy. For example, if the 
magnitude of damage is small, then the opportunity to observe the effect of an intervention is small. 
Similarly, if the duration of performance decrement is acute, when investigating a process (EIMD) 
which possibly stresses protein metabolism maximally from 48 h onwards (Lowe et al., 1995), the 
opportunity to observe the affect of supplementation is reduced. Hence, the muted responses in this 
study, regardless of reason, might act to reduce the possibility of observing any potential beneficial 
effect of protein supplementation on recovery from EIMD. Further, we chose to provide protein 
supplements across the observed recovery period of 72 h, with the aim of increasing bioavailability on 
subsequent days, whereby fractional synthesis rates remain elevated following resistance exercise 
(Phillips et al., 1997). This design ensured an increased quantity of supplemental protein in comparison 
to single bolus models in the literature, of which some have displayed efficacy for protein in supporting 
recovery from muscle damage (Cockburn et al., 2008, Etheridge et al., 2008). It therefore seems 
unlikely that the quantity of protein supplementation provided in this study would explain the lack of 
efficacy in supporting the recovery process.  
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Much of the research relating to EIMD suffers from a limitation, which is often acknowledged, in that 
there is a lack of control concerning habitual diet (Cockburn et al., 2008, Howatson et al., 2012, White 
et al., 2008). This is problematic on two counts; with underlying discrepancies in macronutrient intake 
affecting bioavailability of a given substrate and a likely variance in the energy balance within or 
between experimental groups. Activating the mTORC1 signaling pathway is a pertinent outcome of 
resistance exercise, owing to its regulatory role in muscle protein remodelling (Drummond et al., 2009, 
Philp et al., 2011). A recent review has highlighted the direct or indirect affect that nutrition can have 
on the known inputs that regulate mTORC1; amino acids, glucose, and growth factors (Drummond et 
al., 2009). This is supported by evidence that essential amino acids have a stimulatory effect on muscle 
protein synthesis (Groen et al., 2015) and the observation that carbohydrate ingestion post-resistance 
exercise acts to reduce protein breakdown (Borsheim et al., 2004). Hence, control of nutrient intake 
is of the utmost importance when conducting research involving muscle remodelling as part of the 
recovery process. Great effort was taken in an attempt to account for some of the limitations existing 
in this field of research, with a habitual diet designed in line with ACSM recommendations provided 
to paƌtiĐipaŶts͛ hoŵe addƌesses. A sŵall, but significant reduction in body mass across all subjects was 
observed in the current study, despite the prescription of a diet that was intended to facilitate energy 
balance. It is not possible to compare the response in body mass change with data from the literature, 
as this outcome is seldom reported. It could be argued that this data would be insightful in designs 
possessing discrepancies in energy content between supplemental conditions (Cockburn et al., 2008, 
Hoffman et al., 2010). Such designs, where participants may have experienced a significant energy 
deficit and one experimental group has not been allocated to an iso-caloric supplement control, would 
likely damage the construct validity of research aiming to investigate the efficacy of protein 
supplementation.  
 
The only outcome measure devoid of a significant time effect was 16.1 km TT performance, which was 
only repeated at 72 h, in order to mimic the applied scenario of completing a heavy mid-week training 
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session (0 h) prior to weekend competition (72 h). Hence, any negative effects of the concurrent 
damaging exercise are resolved by 72 h post-exercise and do not negatively affect 16.1 km time trial 
performance. Given the desire to increase ecological validity with the experimental design, it was 
imperative that a well-trained cohort were recruited (V̇O2peak of ϲϭ.Ϯ ŵl∙kg-1∙ŵiŶ-1). However, with 
regards to application, it should be acknowledged that although the 16.1 km TT performance measure 
was assessed at time-points to mimic the applied scenario of completing a heavy mid-week training 
session prior to competition, the exercise events from baseline through to 72 h would not constitute 
a regular training week. This should be taken into consideration when deciding whether the 
oďseƌǀatioŶs fƌoŵ this ƌeseaƌĐh should iŶfoƌŵ aŶ athlete͛s appƌoaĐh to ƌeĐoǀeƌǇ fƌoŵ aŶ iŶteŶse ďout 
of concurrent exercise.  
 
In summary, these data fail to support the efficacy of protein supplementation in attenuating the 
relatively modest indices of EIMD imposed by concurrent exercise, when employing great rigour 
around the provision of a quality habitual diet which met protein intake recommendations and the 
provision of appropriate supplemental controls. They also offer new information regarding the 
recovery from muscle damaging exercise imposed with a concurrent exercise paradigm, in a well-
trained cohort.  
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